Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients.
Chan Mi LeeEunyoung LeeJi Hwan BangWan Beom ParkPyoeng Gyun ChoeMyoung-don OhNam Joong KimPublished in: Infection & chemotherapy (2021)
Tuberculosis (TB) is a common opportunistic infection in human immunodeficiency virus (HIV)-infected patients. Patients with multidrug-resistant (MDR)-TB have poor outcomes. This study aimed to determine the prevalence of MDR-TB in HIV/TB co-infected patients in the Korea. We reviewed the medical records of HIV/TB co-infected patients at two university hospitals between January 1998 and December 2020. During the study period, a total of 87 HIV/TB co-infected patients were identified, and drug susceptibility test results were available for 44 of them. The prevalence of MDR-TB in the study population was 15.9% (7/44, 95% confidence interval, 5.1 - 26.7).
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- mycobacterium tuberculosis
- multidrug resistant
- hiv aids
- hiv infected patients
- hiv infected
- hiv positive
- hepatitis c virus
- hiv testing
- drug resistant
- risk factors
- acinetobacter baumannii
- men who have sex with men
- gram negative
- healthcare
- pseudomonas aeruginosa
- metabolic syndrome
- escherichia coli
- south africa
- skeletal muscle